Numinus CEO Speaks On Australia’s Precedent-Setting Decision To Allow Psychedelic Assisted Therapy Feb 8, 2023
Awakn’s Dr. Ben Sessa: Ketamine Assisted Therapy Providing “Breakthrough, Transformative Experience” Jan 31, 2023
Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
